Cell Biology and Toxicology (CBT) is an international journal focused on clinical and translational research with an emphasis on molecular and cell biology, genetic and epigenetic heterogeneity, drug discovery and development, and molecular pharmacology and toxicology. CBT has a disease-specific scope prioritizing publications on gene and protein-based regulation, intracellular signaling pathway dysfunction, cell type-specific function, and systems in biomedicine in drug discovery and development. CBT publishes original articles with outstanding, innovative and significant findings, important reviews on recent research advances and issues of high current interest, opinion articles of leading edge science, and rapid communication or reports, on molecular mechanisms and therapies in diseases.
SUBJECTS COVERED:
1. Gene and protein-based regulations in diseases
CBT welcomes submissions in the fields of genomics and proteomic, functional genomics and proteomics, computational biology, and gene expression and function. CBT particularly includes aspects of the multifactorial genetics and epigenetics of diseases, disease-specific biomarkers, developmental biology, systems biology and bioinformatics-based data mining approaches with translational potentials.
2. Molecular pharmacology and toxicology
CBT specially focuses on drug target identification and validation, rational drug design, genetic/small molecule (high-throughput) screening, novel therapeutic approaches, combinatorial and parallel synthesis of drugs, pharmacokinetics and pharmacodynamics, pharmacogenomics and toxicogenomics.
3. Pathological mechanisms related with intracellular organelles and cells
CBT publishes novel findings on membrane biology and domains, and the associated receptor and non-receptor mediated signaling and transport proteins of the cell membrane, mitochondria, the endoplasmic reticulum, Golgi apparatus, and other organelles in health and disease. On the cellular and organism level, CBT aims to understanding cancer development, maintenance and treatment resistance, immune and inflammatory cell function, neuroscience, stem cell development and differentiation, epithelial biology and endothelial barrier function.
4. Biomedical aspects of organ systems in diseases
CBT primarily publishes studies on the immune system, central and autonomic nervous systems, gastrointestinal system, cardiovascular and circulatory system, endocrine system, and pulmonary system, skeletal and muscular system, and urinary system to understand deeper about pathogeneses and therapies.

Editor-in-Chief: 

Xiangdong Wang, MD, PhD
Distinguished Professor of Medicine, Director of Shanghai Institute of Clinical Bioinformatics, Director of Fudan University Center for Clinical Bioinformatics, 
Director of Biomedical Research Center of Fudan University Zhongshan Hospital, 
Shanghai, China

Honorary Editors:
Professor Andre Guillouzo
Dr. Charlene McQueen
Michael Welsh

Founding Editor: Gary Williams


Editorial Board 

Angela Hague, School of Oral and Dental Sciences, Faculty of Medicine and Dentistry, Bristol, UK

Timothy C. Marrs, Edentox Associates, Edenbridge, Kent, UK

Xinxin Ding, PhD, Professor, College of Nanoscale Science, SUNY Polytechnic Institute, Albany, NY, USA 

Reen Wu, PhD, Professor of Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of California at Davis, School of Veterinary Medicine, Davis, California, USA 

Kenneth Adler, PhD, Professor of Cell Biology, Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, USA 

Winfried Römer, Prof. Dr.Institute of Biology II and BIOSS Centre for Biological Signalling Studies, Freiburg, Germany 

Benjamin Geiger, Professor of Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot, Israel 

Jörg Grosshans, Professor, Institute for Developmental Biochemistry, Medical School, Georg-August-University Göttingen, Göttingen, Germany 

Jean-Yves Bouet, PhD, CNRS Research Director, Laboratoire de Microbiologie et Génétique Moléculaires, Centre National de la Recherche Scientifique and University of Toulouse Paul Sabatier, Toulouse, France 

Douglas S. Richardson, PhD, Director of Imaging, Harvard Center for Biological Imaging, Department of Molecular and Cellular Biology, Harvard University, Cambridge, USA 

Michael S. Goldberg, Professor, Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, USA 

Dirk Heckl, Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany 

Peter Bai, PhD, DSc, Associate Professor and Head of MTA-DE Lendület Laboratory of Cellular Metabolism, Research Center for Molecular Medicine, Dept. of Medical Chemistry University of Debrecen, Debrecen, Hungary 

Miguel A. Esteban, Professor, Hong Kong-Guangdong Joint Laboratory on Stem Cell and Regenerative Medicine, the University of Hong Kong and Guangzhou Institutes of Biomedicine and Health, China 

Robert Smith, PhD, Professor and Vice President, Cancer Screening, American Cancer Society, Atlanta, USA 

Jean-Yves Bouet, Professor and Head, Laboratoire de Microbiologie et Génétique Moléculaires, Centre National de la Recherche Scientifique, Toulouse, France 

Dan Peer PhD, Professor and Head of Laboratory of NanoMedicine, Department of Cell Research & Immunology, Department of Materials Science & Engineering, Director of FTA:Nanomedicines for Personalized Theranostics, Director of Leona M. and Harry B. Helmsley Nanotechnology Research Fund, Israel 

Darren R. Williams, PhD, Associate Professor, New Drug Targets Laboratory, School of Life Science, Gwangju Institute of Science and Technology, Republic of Korea 

Christian Baumgartner PhD, Professor of Health Care and Biomedical Engineering, Institute of Health Care Engineering with European Notified Body of Medical Devices, Graz University of Technology; Institute of Electrical and Biomedical Engineering-Research Group for Clinical Bioinformatics, University of Health Sciences, Medical Informatics and Technology, Austria 

Tian Xu, PhD, Professor and Vice Chair of Genetics, Yale University School of Medicine, Investigator of Howard Hughes Medical Institute, Director of Institute of Developmental Biology & Molecular Medicine, Fudan University, New Haven, USA

Peter A. Ward, MD, Godfrey D. Stobbe Professor of Pathology, University of Michigan Medical School, Department of Pathology, Ann Arbor, USA 

Gary L Firestone, PhD, Professor of Cell and Developmental Biology, Dept. of Molecular and Cell Biology, The University of California at Berkeley, Berkeley, USA

Drago Cretoiu, MD, PhD, Assistant Professor, Department of Cellular and Molecular Medicine, Faculty of Medicine, 'Carol Davila' University of Medicine and Pharmacy and 'Victor Babes' National Institute of Pathology, Bucharest, Romania